We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

OGT and Cartagenia Collaborate in Automated Aberration Data Transfer

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute
Oxford Gene Technology (OGT) has announced that its CytoSure™ Interpret Software can now transfer array comparative genomic hybridization (aCGH) aberration data directly to Cartagenia’s Bench™ constitutional cytogenetics platform. This helps cytogeneticists accurately correlate genotypic findings with known clinical phenotypes.

Further details of this new functionality will be presented in two workshops at the European Human Genetics Conference 2010 in Gothenburg, Sweden, 12-15 June. On 12 June, OGT will present “From disease to cytogenetics research – An integrated CNV analysis platform from Oxford Gene Technology” at 12.00 in room H1. Following on from this at 14.00 in room R4, Cartagenia will present “Routine clinical interpretation of copy number variation”.

With the ability to automatically detect CNV aberrations, CytoSure Interpret Software generates reproducible results, which can be cross referenced with external aberration databases for accurate data interpretation. These results can now be transferred to Cartagenia’s Bench platform, allowing additional data management options - including secure data sharing within, and across, various research facilities - and support for genotype-phenotype correlation analysis.

OGT and Cartagenia will be exhibiting at ESHG 2010 on booths B-550 and B-632 respectively.